Connect with us

Hi, what are you looking for?

DMN Stories

Judge denies AG Paxton’s bid for bar on Tylenol marketing in state

Drug maker says Texas attorney general has “reached far beyond the state’s jurisdiction.”

By Tribune News Service
Dallas Morning News
https://www.dallasnews.com/

Texas Attorney General Ken Paxton speaks at an event hosted by the University of Texas chapter of Turning Point USA on campus in Austin, Monday, Nov. 3, 2025.
Mikala Compton / Austin American-Statesman

A judge rejected for now a bid by Texas Attorney General Ken Paxton to bar Tylenol-maker Kenvue Inc. from marketing its over-the-counter pain medication as being safe for pregnant women within the state.

After a hearing Friday, State District Judge LeAnn Rafferty denied Paxton’s request for a temporary restraining order, court records show.

Experts say there’s no clear connection between the use of acetaminophen (the active ingredient in Tylenol) during pregnancy and adverse neurobehavioral or developmental outcomes such as autism. Kenvue has pushed back against this link, saying the claims are unsupported by scientific evidence. Untreated fevers and pain are known risks during pregnancy.

In a statement, Kenvue said the attempt by Texas to block marketing of Tylenol had “reached far beyond the state’s jurisdiction, defied science, and placed the health of women and children at risk.”

“Their tactics are politically and financially motivated and have nothing to do with the health and safety of consumers. We will continue to do everything in our power to stand up for sound, credible science.”

Paxton has been state attorney general since 2015 and is a longtime ally of President Donald Trump, who ignited scrutiny of Tylenol in September when he said pregnant women shouldn’t take it.

Advertisement. Scroll to continue reading.

He didn’t cite scientific evidence to support his recommendation. Paxton is currently running for one of Texas’ U.S. Senate seats.

Kimberly-Clark Corp. announced Nov. 3 it would buy Kenvue for roughly $40 billion.

The companies say they carefully considered the potential risk of lawsuits related to Tylenol before moving forward with the deal, though analysts warned investors could be wary of the acquisition given the mounting legal issues.

In his request for the temporary order, Paxton also had asked that Kenvue be blocked from issuing its dividend. The judge rejected that. Paxton argued any dividends paid by Kenvue would violate a Texas law prohibiting people and businesses from moving assets in order to avoid paying debts or fulfilling other obligations.

This story, originally published in The Dallas Morning News, is reprinted as part of a collaborative partnership between The Dallas Morning News and Texas Metro News. The partnership seeks to boost coverage of Dallas’ communities of color, particularly in southern Dallas.

ADVERTISEMENT

News Video

IMM Mask Promos

I Messenger Media Radio Shows

ADVERTISEMENT

Related Articles

Editorial

By Roy Douglas MalonsonAframNewshttps://aframnews.com/ Every election year, a familiar pattern unfolds across Houston’s Black communities. The streets get busier. Church pews get more crowded...

Lifestyle

By Phenix S Halley The Root https://www.theroot.com/ Take a peek inside the home of one of the greatest African American men in history, Frederick...

News

Check out Beaux on pages 11-14 Special to Texas Metro News Once again, the Dallas Chapter of Jack and Jill Inc. will bring together...

News

Who is John Barron? The question surged after a caller by that name, whose voice resembled President Donald Trump, phoned into C-SPAN on Feb....

Advertisement